Home600535 • SHA
Tasly Pharmaceutical Group Co Ltd
¥13.11
Jul 19, 3:59:48 PM GMT+8 · CNY · SHA · Disclaimer
Stock
Previous close
¥12.98
Day range
¥12.88 - ¥13.12
Year range
¥12.24 - ¥18.00
Market cap
19.24B CNY
Avg Volume
10.87M
P/E ratio
17.86
Dividend yield
2.52%
Primary exchange
SHA
Market news
.DJI
0.97%
NDAQ
0.18%
NFLX
0.71%
MSFT
0.53%
Financials
Income Statement
Revenue
Net income
(CNY)Mar 2024Y/Y change
Revenue
2.05B-1.73%
Operating expense
981.43M4.30%
Net income
295.21M11.58%
Net profit margin
14.4113.55%
Earnings per share
EBITDA
497.60M-6.65%
Effective tax rate
21.74%
Total assets
Total liabilities
(CNY)Mar 2024Y/Y change
Cash and short-term investments
4.86B8.99%
Total assets
17.52B-1.41%
Total liabilities
4.54B-8.24%
Total equity
12.98B
Shares outstanding
1.49B
Price to book
1.53
Return on assets
5.76%
Return on capital
6.32%
Net change in cash
(CNY)Mar 2024Y/Y change
Net income
295.21M11.58%
Cash from operations
-336.91M-324.05%
Cash from investing
-295.64M75.36%
Cash from financing
687.06M-15.46%
Net change in cash
54.66M122.73%
Free cash flow
33.97M113.52%
About
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines. It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange. In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation. In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Founded
1994
Website
Employees
9,223
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu